在澳大利亚,酒精含量低于最佳的摄取量和强制性酒精怀孕警告标签的放置
Tazman Davies1, Paula O'Brien2, Jacqueline Bowden3
1The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, NSW 2042, Australia.
The International journal on drug policy
|November 24, 2024
概括
澳大利亚的酒精产品显示适度吸收强制性怀孕警告标签. 大多数标签都在背面,建议提高可见性和更广泛的应用,以保护孕妇.
科学领域:
- 公共卫生 公共卫生
- 酒精政策 酒精政策
- 消费者信息 消费者信息
背景情况:
- 强制性怀孕警告标签对于告知消费者怀孕期间酒精风险至关重要.
- 澳大利亚从2023年8月1日起实施了强制性怀孕警告标签政策,用于酒精饮料.
- 评估这些标签的初始采用和放置对于公共卫生有效性至关重要.
研究的目的:
- 评估澳大利亚酒精饮料上强制性怀孕警告标签的采用率.
- 为了确定怀孕警告标签在各种酒精产品容器上的位置.
- 确定在实施酒精警告标签方面需要改进的潜在领域.
主要方法:
- 一项横截面研究分析了2023年8月至11月期间来自澳大利亚主要零售商的4026种独特酒精饮料的图像.
- 数据收集者评估了强制性怀孕警告标签的存在和位置 (前,后,侧,上,下).
- 分析按六个不同的酒精产品类别进行了分层分析.
主要成果:
- 强制性怀孕警告标签的总体采用率为63%,产品类型之间存在显著差异.
- 烈酒的摄入量最低 (50%),而"其他"饮料如萨克和苏州的摄入量最高 (91%).
- 标签主要放置在产品背面 (88%),在正面 (0.3%) 存在的最小.
结论:
- 政策制定者应该考虑将授权扩展到所有酒精饮料,而不仅仅是新标签的酒精饮料,以确保全面覆盖.
- 修订现有法规可能是必要的,以确保怀孕警告标签更突出地显示,以提高突出性.
- 改善标签放置和确保更广泛的应用可以加强关于怀孕期间饮酒的公共卫生信息.
相关概念视频
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Pharmacovigilance
773
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
773
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Physiological Barriers
3.4K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
3.4K
Drug Control Governance: Regulatory Bodies and Their Impact
141
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
141
Factors Influencing Drug Absorption: Presystemic Elimination
180
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
180


